Skip to content

Axenic Health Solutions

Total raised

$175K

+$175K this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $175K
ROUNDS
1
INVESTORS
3
FOUNDED
N/A
HQ
Libertyville, IL
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
N/A

AI overview

Updated

Axenic Health Solutions, Inc. is a Libertyville, Illinois infection-prevention company founded in 2017 that sources and sells clinically tested disinfection products to U.S. healthcare providers. Its own Q Shield line of patent-pending multi-SiQuat hand and surface sanitizers is designed to leave a durable antimicrobial coating rather than a single-moment kill, and Q Shield Hand is registered with the FDA as an OTC benzalkonium chloride skin antiseptic. It also brings third-party disinfection hardware to the U.S. market, including the THOR UVC continuous-wave ultraviolet disinfection robot and Q Shield bio-fogging surface treatment systems. The company has said it is developing software-based subscription services for real-time pathogen exposure monitoring and containment tracking across facilities.

What sets it apart

Patent-pending multi-SiQuat chemistry marketed as leaving a durable protective film on hands and surfaces, paired with a curated portfolio of imported disinfection hardware, so a hospital can buy chemistry, UVC hardware, and program design from one vendor.

Funding history

1 round
EquityMar 25, 2026 · $25K min
Form D
+$175K$175K total

Latest SEC filings

via EDGAR · CIK 0001749418
Form D · Mar 25, 2026View on EDGAR

Products

1 tracked

Q Shield

Infection prevention products

A branded line of hand and surface sanitizer products built on patent-pending multi-SiQuat formulas, sold to healthcare organizations and other commercial buyers to reduce healthcare-associated infections. Q Shield Hand is an FDA-listed OTC hand and skin antiseptic with 0.13% benzalkonium chloride; Q Shield surface products are applied as a bio-fogging and surface treatment system that leaves an invisible protective coating.

  • Patent-pending multi-SiQuat formulation for both hands and hard surfaces
  • Q Shield Hand FDA-listed as an OTC benzalkonium chloride 0.13% skin antiseptic
  • Bio-fogging application for whole-room surface treatment
  • Third-party laboratory testing on pathogen kill, including SARS-CoV-2 surrogate testing

Links

LinkedInSEC EDGAR filings